University of Minnesota. Driven to Discover.
Trials of both an inactivated and a DNA vaccine showed good safety and immune response data.
A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.
Scientists manipulate mosquitoes' abilities to host the parasite Plasmodium falciparum.
Recommendations focus on public-private R&D funding, incentives, and other steps.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.